(2R,6R)-6-[(1S,3R,6S,8R,11S,12S,15R,16R)-6-hydroxy-7,7,12,16-tetramethyl-15-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-methyl-3-methylideneheptanoic acid

Details

Top
Internal ID 14cc1eb7-4551-4af1-86e7-9c0ee700d3e1
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Cycloartanols and derivatives
IUPAC Name (2R,6R)-6-[(1S,3R,6S,8R,11S,12S,15R,16R)-6-hydroxy-7,7,12,16-tetramethyl-15-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-methyl-3-methylideneheptanoic acid
SMILES (Canonical) CC(CCC(=C)C(C)C(=O)O)C1CCC2(C1(CCC34C2CCC5C3(C4)CCC(C5(C)C)O)C)C
SMILES (Isomeric) C[C@H](CCC(=C)[C@@H](C)C(=O)O)[C@H]1CC[C@@]2([C@@]1(CC[C@]34[C@H]2CC[C@@H]5[C@]3(C4)CC[C@@H](C5(C)C)O)C)C
InChI InChI=1S/C31H50O3/c1-19(21(3)26(33)34)8-9-20(2)22-12-14-29(7)24-11-10-23-27(4,5)25(32)13-15-30(23)18-31(24,30)17-16-28(22,29)6/h20-25,32H,1,8-18H2,2-7H3,(H,33,34)/t20-,21-,22-,23+,24+,25+,28-,29+,30-,31+/m1/s1
InChI Key FCQSIIVNJCMJLB-SRBJWBKWSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C31H50O3
Molecular Weight 470.70 g/mol
Exact Mass 470.37599545 g/mol
Topological Polar Surface Area (TPSA) 57.50 Ų
XlogP 9.20
Atomic LogP (AlogP) 7.48
H-Bond Acceptor 2
H-Bond Donor 2
Rotatable Bonds 6

Synonyms

Top
13878-93-8
CHEMBL3926423

2D Structure

Top
2D Structure of (2R,6R)-6-[(1S,3R,6S,8R,11S,12S,15R,16R)-6-hydroxy-7,7,12,16-tetramethyl-15-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-methyl-3-methylideneheptanoic acid

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9950 99.50%
Caco-2 - 0.6967 69.67%
Blood Brain Barrier - 0.6250 62.50%
Human oral bioavailability - 0.5714 57.14%
Subcellular localzation Mitochondria 0.7434 74.34%
OATP2B1 inhibitior - 0.5614 56.14%
OATP1B1 inhibitior + 0.8815 88.15%
OATP1B3 inhibitior + 0.7974 79.74%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.5750 57.50%
BSEP inhibitior + 0.6809 68.09%
P-glycoprotein inhibitior - 0.5683 56.83%
P-glycoprotein substrate - 0.7267 72.67%
CYP3A4 substrate + 0.6450 64.50%
CYP2C9 substrate - 0.6653 66.53%
CYP2D6 substrate - 0.8408 84.08%
CYP3A4 inhibition - 0.7880 78.80%
CYP2C9 inhibition - 0.7842 78.42%
CYP2C19 inhibition - 0.8429 84.29%
CYP2D6 inhibition - 0.9492 94.92%
CYP1A2 inhibition - 0.8827 88.27%
CYP2C8 inhibition - 0.7014 70.14%
CYP inhibitory promiscuity - 0.7847 78.47%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 1.0000 100.00%
Carcinogenicity (trinary) Non-required 0.6617 66.17%
Eye corrosion - 0.9941 99.41%
Eye irritation - 0.9260 92.60%
Skin irritation + 0.5727 57.27%
Skin corrosion - 0.9473 94.73%
Ames mutagenesis - 0.7965 79.65%
Human Ether-a-go-go-Related Gene inhibition - 0.4830 48.30%
Micronuclear - 0.8000 80.00%
Hepatotoxicity - 0.6968 69.68%
skin sensitisation - 0.5772 57.72%
Respiratory toxicity + 0.5556 55.56%
Reproductive toxicity + 0.9333 93.33%
Mitochondrial toxicity + 0.9875 98.75%
Nephrotoxicity - 0.8617 86.17%
Acute Oral Toxicity (c) I 0.4877 48.77%
Estrogen receptor binding + 0.7045 70.45%
Androgen receptor binding + 0.7704 77.04%
Thyroid receptor binding + 0.6368 63.68%
Glucocorticoid receptor binding + 0.7480 74.80%
Aromatase binding + 0.7419 74.19%
PPAR gamma + 0.6576 65.76%
Honey bee toxicity - 0.7756 77.56%
Biodegradation - 0.7500 75.00%
Crustacea aquatic toxicity - 0.7400 74.00%
Fish aquatic toxicity + 1.0000 100.00%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 96.20% 96.09%
CHEMBL253 P34972 Cannabinoid CB2 receptor 95.54% 97.25%
CHEMBL2581 P07339 Cathepsin D 92.69% 98.95%
CHEMBL3807 P17706 T-cell protein-tyrosine phosphatase 92.33% 93.00%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 92.29% 91.11%
CHEMBL221 P23219 Cyclooxygenase-1 91.83% 90.17%
CHEMBL218 P21554 Cannabinoid CB1 receptor 91.72% 96.61%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 88.89% 94.45%
CHEMBL335 P18031 Protein-tyrosine phosphatase 1B 88.77% 95.17%
CHEMBL3359 P21462 Formyl peptide receptor 1 87.41% 93.56%
CHEMBL4227 P25090 Lipoxin A4 receptor 87.34% 100.00%
CHEMBL3137262 O60341 LSD1/CoREST complex 85.97% 97.09%
CHEMBL340 P08684 Cytochrome P450 3A4 85.91% 91.19%
CHEMBL237 P41145 Kappa opioid receptor 85.10% 98.10%
CHEMBL3130 O00329 PI3-kinase p110-delta subunit 84.57% 96.47%
CHEMBL3492 P49721 Proteasome Macropain subunit 84.17% 90.24%
CHEMBL2514 O95665 Neurotensin receptor 2 83.74% 100.00%
CHEMBL233 P35372 Mu opioid receptor 83.53% 97.93%
CHEMBL4040 P28482 MAP kinase ERK2 82.37% 83.82%
CHEMBL220 P22303 Acetylcholinesterase 82.18% 94.45%
CHEMBL3837 P07711 Cathepsin L 81.80% 96.61%
CHEMBL4246 P42680 Tyrosine-protein kinase TEC 81.73% 82.05%
CHEMBL3145 P42338 PI3-kinase p110-beta subunit 81.52% 98.75%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 80.63% 95.89%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 80.27% 95.56%

Cross-Links

Top
PubChem 101286241
NPASS NPC166825